Hepatocellular carcinoma (HCC) mortality rates are increasing globally, and particularly in
the Western world. Cirrhosis remains the predominant risk factor for HCC. However …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Purpose Models of integrated, multidisciplinary care are optimal in the setting of complex,
chronic diseases and in the overlap of medical and mental health disease, both of which …

Background & Aims Hepatocellular carcinoma (HCC) surveillance is associated with
improved early detection and reduced mortality, although practice patterns and effectiveness …

Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer-
related death. The remarkable improvements in treating HCC achieved in the last years …

Importance Cohort studies demonstrating an association of hepatocellular carcinoma (HCC)
screening with reduced mortality are prone to lead-time and length-time biases. Objective To …

Hepatocellular carcinoma (HCC) is a leading contributor to cancer-related deaths worldwide
and presents significant challenges in diagnosis and treatment due to its heterogeneous …

Hepatocellular carcinoma (HCC) represents a significant burden on global healthcare
systems due to its considerable incidence and mortality rates. Recent trends indicate an …

Background: Racial and ethnic disparities in hepatocellular carcinoma (HCC) prognosis
exist, partly related to differential failures along the cancer care continuum. We characterized …

Liver transplantation is the curative therapy of choice for patients with early-stage HCC.
Locoregional therapies are often employed as a bridge to reduce the risk of waitlist dropout; …